American-Italian Cancer Foundation

Vitamin A compound may help protect younger women against breast and ovarian cancers

A five-year clinical trial found that premenopausal women taking fenretinide had a lower risk of developing another breast cancer, while postmenopausal women showed no significant benefit. The study also detected a reduced risk of ovarian cancer in younger women treated with fenretinide.